168608-39-7 Usage
Description
(3S,4S,5R)-5-(((tert-butyldiphenylsilyl)oxy)methyl)tetrahydrofuran-2,3,4-triol is a complex organic compound characterized by a tetrahydrofuran ring structure and multiple hydroxyl groups. It is a derivative of tetrahydrofuran-2,3,4-triol, featuring a tert-butyldiphenylsilyl group attached to one of the hydroxyl groups. This specific stereochemistry and the presence of functional groups make it a versatile building block or reagent in organic synthesis for the preparation of other compounds.
Uses
Used in Organic Synthesis:
(3S,4S,5R)-5-(((tert-butyldiphenylsilyl)oxy)methyl)tetrahydrofuran-2,3,4-triol is used as a building block for the synthesis of various complex organic molecules. Its unique structure and functional groups allow it to participate in a wide range of chemical reactions, making it a valuable precursor for the creation of more intricate molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (3S,4S,5R)-5-(((tert-butyldiphenylsilyl)oxy)methyl)tetrahydrofuran-2,3,4-triol is used as a key intermediate in the development of new drugs. Its specific stereochemistry and functional groups can be exploited to design and synthesize novel bioactive compounds with potential therapeutic applications.
Used in Material Science:
(3S,4S,5R)-5-(((tert-butyldiphenylsilyl)oxy)methyl)tetrahydrofuran-2,3,4-triol can also be utilized in material science for the development of new materials with specific properties. Its structural features and reactivity make it a promising candidate for the synthesis of advanced materials with applications in various fields, such as electronics, coatings, and adhesives.
Used in Chemical Research:
As a complex organic compound with unique structural features, (3S,4S,5R)-5-(((tert-butyldiphenylsilyl)oxy)methyl)tetrahydrofuran-2,3,4-triol is used in chemical research to study various aspects of organic chemistry, including reaction mechanisms, stereochemistry, and the development of new synthetic methods. Its versatile reactivity and structural characteristics make it an interesting subject for scientific investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 168608-39-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,8,6,0 and 8 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 168608-39:
(8*1)+(7*6)+(6*8)+(5*6)+(4*0)+(3*8)+(2*3)+(1*9)=167
167 % 10 = 7
So 168608-39-7 is a valid CAS Registry Number.
168608-39-7Relevant articles and documents
Elongation of the side chain by linear alkyl groups increases the potency of salacinol, a potent α-glucosidase inhibitor from the Ayurvedic traditional medicine “Salacia,” against human intestinal maltase
Takashima, Katsuki,Sakano, Mika,Kinouchi, Eri,Nakamura, Shinya,Marumoto, Shinsuke,Ishikawa, Fumihiro,Ninomiya, Kiyofumi,Nakanishi, Isao,Morikawa, Toshio,Tanabe, Genzoh
supporting information, (2020/12/30)
Four chain-extended analogs (12a–12d) and two related de-O-sulfonated analogs (13a and 13c) by introducing alkyl groups (a: R = C3H7, b R = C6H13, c: R = C8H17, d: R = C10H2
CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS
-
Paragraph 1486; 1487; 1488, (2019/02/13)
The present invention is directed to compounds of the formulae I, II and III as shown below wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Structure-activity relationship studies on acremomannolipin A, the potent calcium signal modulator with a novel glycolipid structure 3: Role of the length of alditol side chain
Tsutsui, Nozomi,Tanabe, Genzoh,Morita, Nao,Okayama, Yoshitomo,Kita, Ayako,Sugiura, Reiko,Muraoka, Osamu
, p. 3761 - 3773 (2015/08/03)
Abstract Five homologs of a novel glycolipid acremomannolipin A (1a), the potential Ca2+ signal modulator isolated from Acremonium strictum, bearing alditols of different length (1g-1k) were synthesized by a stereoselective β-mannosylation of a